Development and Validation of a Recombinant VP2-Based Indirect ELISA for Canine Parvovirus
Microorganisms · 21.05.2026 · 14 (5) · 1161
DOI: 10.3390/microorganisms14051161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 21.05.2026. Verfasst von Bocheng Gao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Nanchang City Key Laboratory of Animal Virus and Genetic Engineering, College of Bioscience and Engineering, Institute of Pathogenic Microorganism, J…. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study aimed to express the canine parvovirus (CPV) VP2 protein prokaryotically and develop an indirect ELISA for detecting CPV-specific antibodies in canine serum. The VP2 gene from a laboratory-isolated CPV strain was amplified and cloned into the pET-28a vector. Following prokaryotic expression optimization, the recombinant protein was purified via Ni-NTA affinity chromatography and validated using Western blotting. An indirect ELISA was established utilizing the purified VP2 as the coating antigen, with optimal parameters determined by checkerboard titration. A 1773 bp VP2 fragment was amplified. Optimal expression of the 64.8 kDa recombinant VP2 was achieved with 2 mmol/L isopropyl β-D-thiogalactoside (IPTG) at 32 °C for 8 h. For the indirect ELISA, the optimal antigen coating concentration was 2 μg/mL, alongside primary (canine serum) and secondary antibody dilutions of 1:320 and 1:4000, respectively. The diagnostic cut-off optical density at 450 nm (OD450) threshold was established at ≥0.2066, and the analytical sensitivity reached a serum dilution of 1:5120. Compared with the hemagglutination inhibition (HI) assay using 192 clinical serum samples, the ELISA showed a diagnostic sensitivity of 85.94%, a diagnostic specificity of 88.28%, and an overall agreement rate of 87.50%. The mean intra-assay and inter-assay coefficients of variation were 4.39% and 3.02%, respectively. These findings indicate that the recombinant VP2-based indirect ELISA showed good analytical sensitivity, reproducibility, and diagnostic agreement with the HI assay for detecting CPV-specific antibodies in canine serum under the tested conditions, although broader cross-reactivity validation is still required.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nanchang City Key Laboratory of Animal Virus and Genetic Engineering, College of Bioscience and Engineering, Institute of Pathogenic Microorganism, Jiangxi Agricultural University, Nanchang 330045, China.
- Key Laboratory of Agricultural Resource and Ecology in the Poyang Lake Basin of Jiangxi Province, School of Land Resources and Environment, Jiangxi Agricultural University, Nanchang 330045, China.
ORCID-Profile: Bocheng Gao, Jiale Yi, Jing Liu
Zitieren
APA
Gao, B., Yi, J., Gai, L., Liu, J., Min, X., Yao, J., Li, M., Liu, J., Chen, Y., Wu, S., Hu, Y., & Kong, L. (2026). Development and Validation of a Recombinant VP2-Based Indirect ELISA for Canine Parvovirus. Microorganisms, 14(5), 1161. https://doi.org/10.3390/microorganisms14051161
Vancouver
Gao B, Yi J, Gai L, Liu J, Min X, Yao J, et al. Development and Validation of a Recombinant VP2-Based Indirect ELISA for Canine Parvovirus. Microorganisms. 2026;14(5):1161. doi:10.3390/microorganisms14051161
BibTeX
@article{Gao2026,
author = {Gao, Bocheng and Yi, Jiale and Gai, Linna and Liu, Jing and Min, Xuan and Yao, Ju and Li, Mingzhi and Liu, Jiarong and Chen, Yule and Wu, Su and Hu, Yunzi and Kong, Lingbao},
title = {Development and Validation of a Recombinant VP2-Based Indirect ELISA for Canine Parvovirus},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {5},
pages = {1161},
doi = {10.3390/microorganisms14051161}
}
EUVIMED